Zacks Investment Research on MSN

Organon secures FDA approval extending NEXPLANON use to five years

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...

Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel i…

Organon's NEXPLANON receives U.S. FDA sNDA approval for extended duration of use up to five years, including data for use in ...

Organon wins FDA nod to expand use of Nexplanon birth control implant

Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three ...